0
Controversies in Neurology |

Botulinum Toxin Type A for the Treatment of Headache:  Why We Say Yes

Avi Ashkenazi, MD; Stephen Silberstein, MD, FACP
Arch Neurol. 2008;65(1):146-149. doi:10.1001/archneurol.2007.20.
Text Size: A A A
Published online

Extract

Botulinum toxin type A (BoNT-A) has long been used to treat disorders associated with increased muscle tone. Support for an analgesic effect of BoNT-A independent of its muscle relaxation effect came from clinical observations that some patients with dystonia obtained pain relief before they obtained improvement in muscle tone.1 Injections of BoNT-A were discovered serendipitously to alleviate migraine headache when they were given for the treatment of facial wrinkles.2 After several open-label studies showed that BoNT-A might have efficacy in headache treatment, randomized controlled trials were initiated to investigate this issue further.3 New scientific data have provided insight into mechanisms by which BoNT-A may exert its analgesic effect. In our discussion, we focus on clinical data obtained from randomized controlled trials.

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
/>
First page PDF preview

Figures

Tables

References

Correspondence

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...
Articles Related By Topic
Related Topics
PubMed Articles
Jobs
brightcove.createExperiences();